Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
US FDA Approves Genentech’s Enspryng, the First Subcutaneous Treatment for TED
Genentech and its parent, Roche, announced Oct. 16 that the US FDA had approved Enspryng (satralizumab-mwge) for the treatment of adults with thyroid eye disease (TED). It’s the first at-home, subc...
Alvotech, Advanz Submit Marketing Application to EMA for High-Dose Aflibercept Biosimilar
Alvotech and partner Advanz Pharma announced Oct. 14 that they had submitted a marketing authorization application to the European Medicines Agency (EMA) for AVT29, a proposed biosimilar to Eylea (...
Merck Sees Mixed Results at One Year in Pivotal Trial of Remigromig in DME
Merck presented one-year results from remigromig’s pivotal Phase IIb/III BRUNELLO trial at the 2026 meeting of the American Academy of Ophthalmology (AAO), held Oct. 10-12 in New Orleans, Louisiana...
Saunders Departs Bausch + Lomb, as Chairman Appio Takes Over
Bausch + Lomb announced Oct. 12 that CEO Brent Saunders would leave the company immediately, with chairman Thomas Appio taking over as interim CEO. Appio also is CEO of Bausch Health. Saunders had ...
US FDA Accepts BLA for Genentech’s Vamikibart in UME; Decision Expected by July 2027
Genentech, a member of the Roche group, reported Oct. 10 that the US FDA had accepted the biologics license application (BLA) for vamikibart, an intravitreal IL-6 inhibitor candidate for uveitic ma...
Visara Licenses Topical Neurotrophic Keratitis Candidate from China’s Hiteck
Visara, the ophthalmic subsidiary of NovaBridge Biosciences, announced Oct. 13 that it had licensed a topical candidate targeting neurotrophic keratitis (NK) from China’s Wuhan Hiteck Biopharma. VI...
Corza Medical Launches Expanded Single-Use Custom Packs
Corza Medical, of Boulder, Colorado, announced Oct. 10 the launch of its expanded Blink single-use custom surgical packs. The company also debuted a new automated manufacturing process for its Shar...
HelpMeSee Names Former Test Pilot Doug May as President and CEO
Global nonprofit group HelpMeSee announced Oct. 1 that it had appointed Doug May as president and chief executive officer. May joined HelpMeSee in 2025 as chief operating officer. He previously wor...
Glaukos Licenses Tri-specific Retinal Candidate RO-104 from RevOpsis
Glaukos announced Oct. 8 that it had licensed from RevOpsis Therapeutics the exclusive rights to develop and commercialize RO-104, a novel tri-specific biologic candidate targeting wet age-related ...
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot (formerly Virtual Field) reported Oct. 9 that it had agreed to acquire GreenMan Vision, of West Fargo, North Dakota, and its InSightVR IOL simulator. No financial details were provided. The ...
Sagent Launches Zyogreen Ready-to-Use Indocyanine Green Dye for Injection in the US
Sagent Pharmaceuticals, of Schaumburg, Illinois, announced Sept. 22 the US launch of Zyogreen (indocyanine green injection). Sagent said Zyogreen is the first and only FDA-approved ready-to-use ind...
Study Indicates that Circadian Rhythm and Light May Affect IOP
Researchers at the University of South Florida (USF) reported Sept. 30 that continuously monitoring intraocular pressure (IOP) in a rat model showed that eye pressure follows a daily rhythm, consis...
Past News Stories
Nobel Prize for Medicine Goes to Team First to Publish Optogenetics Findings
Three scientists who helped develop optogenetics received the 2026 Nobel Prize in Physiology or Medicine on Oct. 5. They are Karl Deisseroth, MD, PhD, of the Howard Hughes Medical Institute in Mary...
VEO Ophthalmics to Market the VitaPixel Visualization System for Slit Lamps
VEO Ophthalmics and VitaPixel announced a collaboration Oct. 2 under which VEO will market the VitaPixel SVS, a stereoscopic digital visualization system for slit lamps. The VitaPixel SVS combines ...
Japanese Regulators Accept NDA for Nanoscope’s Optogenetic Gene Therapy Candidate, Grant Priority Review
Nanoscope Therapeutics announced Oct. 1 that regulators in Japan had accepted the company’s new drug application for Mogenry, an optogenetic gene therapy candidate targeting inherited retinal dystr...
US FDA Gives Green Light to Trial of Surrozen’s DME Candidate
Surrozen announced on Oct. 2 that the US FDA had signed off on its investigational new drug application, allowing the company to proceed with a clinical trial of SZN-8141, a bifunctional Wnt agonis...
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Pharma announced Oct. 1 that it had acquired all outstanding shares of common stock in Advanced Vision Science (AVS), a manufacturer of intraocular lenses and lens materials, for $13 milli...
MyEyeDr. Acquires Optometry Division of EyeCare Partners
MyEyeDr., of Vienna, Virginia, announced Sept. 28 that it would acquire the optometry division of EyeCare Partners, of St. Louis, Missouri. The deal covers the optometric brands of Clarkson Eyecare...
Aldeyra to File Formal Dispute with US FDA over Reproxalap Rejection
Aldeyra Therapeutics reported Sept. 29 that it would submit a formal dispute resolution request with the US FDA over the rejection of reproxalap, a topical treatment candidate for dry eye disease. ...
Ocugen Gains Provisional Approval in Bahamas to Treat RP Patients with OCU400
Ocugen announced Sept. 25 that OCU400, its subretinal modifier gene therapy candidate targeting retinitis pigmentosa (RP), had been granted provisional approval and priority designation by regulato...
Sightpath Medical Adds Retinal Equipment to Mobile Offering
Sightpath Medical reported Sept. 22 that it now delivers retinal equipment for ophthalmic surgery. The company’s mobile services for retina specialists include delivery of a vitrectomy platform in ...
iRegene’s RP Cell Therapy Candidate Gets Green Light for Clinical Trials in China, US
China’s iRegene Therapeutics announced Sept. 29 that its cell therapy candidate targeting retinitis pigmentosa (RP) gained authorization from regulators to enter clinical trials in both China and t...
InSightVR IOL Simulator Linked to Increased Premium Lens Selection, Better Understanding
GreenMan Vision, of West Fargo, North Dakota, reported Sept. 21 that its InSightVR IOL simulator was associated with several key benefits in a study published Sept. 5 in the journal Patient Prefere...
Claris Bio Establishes Corporate Headquarters in San Francisco
Claris Bio reported Sept. 24 that it had moved its corporate headquarters from Jersey City, New Jersey, to San Francisco, California. Its new home is at 701 Gateway Blvd., Suite 250, South San Fran...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.